期刊文献+

子宫内膜增生及内膜癌中PTEN、Ki-67蛋白的表达 被引量:19

Expression of PTEN and Ki-67 in endometrial hyperplasia and endometrial carcinoma
下载PDF
导出
摘要 目的 研究子宫内膜增生组织及内膜癌组织中PTEN、Ki 6 7蛋白的异常表达 ,探讨其与子宫内膜癌变的关系及作为早期癌变生物学标志的可能性。方法 应用免疫组化S P法对 12例正常增生期子宫内膜组织、4 0例子宫内膜增殖症组织、4 2例内膜腺癌组织中PTEN、Ki 6 7蛋白的表达进行研究。结果 在正常增生期子宫内膜、子宫内膜增殖症 (单纯增生、复杂型增生、不典型增生 )、子宫内膜腺癌组织中PTEN蛋白的阳性表达率呈递减趋势 ;Ki 6 7蛋白的阳性表达率呈递增趋势。等级相关分析结果显示PTEN、Ki 6 7表达异常与子宫内膜组织学分级均显著相关 (相关系数r分别为 - 0 5 4 1和 0 4 96 ,P值均<0 0 1)。子宫内膜癌与除不典型增生外的子宫内膜增殖症组织及正常增生期子宫内膜组织的PTEN、Ki 6 7蛋白表达差异有显著性 ,正常增生期子宫内膜、单纯增生与不典型增生组织的PTEN蛋白表达差异有显著性 ,不典型增生与单纯增生组织的Ki 6 7蛋白表达差异有显著性。PTEN、Ki 6 7蛋白表达存在负相关性 (r =- 0 4 2 8,P <0 0 1)。PTEN、Ki 6 7蛋白的表达与子宫内膜癌的手术分期、组织学分级、肌层浸润无关 (P >0 0 5 )。结论 PTEN、Ki 6 7蛋白的异常表达与子宫内膜的癌变过程相关 ,PTEN基因表达异常及细胞增殖异常与子宫内膜? Purpose To investigate alterations in expression of PTEN and Ki 67 proteins in endometrial carcinogenesis. Methods The expression of PTEN and Ki 67 proteins was detected by immunohistochemical staining S P method in 12 cases of normal proliferative endometrium and 40 cases of endometrial hyperplasia and 42 cases of endometrial adenocarcinoma. Results The positive expression rates of PTEN in normal proliferative endometrium, endometrial hyperplasia and endometrial carcinoma were gradually decreased, while that of Ki 67 protein in these samples were gradually increased. Expression of PTEN and Ki 67 was correlated well with the pathological grading of endometrium. Negative correlation was also found between PTEN and Ki 67 expression. There was significant difference in the expression of PTEN and Ki 67 between normal proliferative endometrium, endometrial hyperplasia (except for atypical hyperplasia) and endometrial carcinoma ( P< 0 05). The expression of PTEN and Ki 67 proteins was not significantly associated with surgical stage, histologic grades and myometrial invasion of endometrial carcinoma ( P >0 05). Conclusions Abnormal expression of PTEN and Ki 67 proteins is associated with carcinogenesis of endmotrium. There are early events in endometrial carcinogenesis and useful biomarkers for early detection.
出处 《临床与实验病理学杂志》 CAS CSCD 2003年第2期152-155,共4页 Chinese Journal of Clinical and Experimental Pathology
关键词 KI-67蛋白 PTEN 不典型增生 增生期 正常 表达 子宫内膜 学分 显著性 结论 endometrial hyperplasia endometrial neoplasms adenocarcinoma immunohistochemistry PTEN Ki 67
  • 相关文献

参考文献7

  • 1Tashiro H, Blazes MS, Wu R, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res, 1997,57:3935~40.
  • 2Mutter GL, Lin MC, Fitzgerald JT, et al. Altered PTEN expression as a diagnostic mark for the earliest endometrial precancers. J Natl Cancer Inst, 2000,92:924~31.
  • 3Mutter GL, Ince TA, Baak JP, et al. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res, 2001,61(11):4311~4.
  • 4郭双平,翟宇强,王文亮,马福成,李华明.肾细胞癌中抑癌基因PTEN的表达及生物学意义[J].临床与实验病理学杂志,2002,18(3):260-263. 被引量:5
  • 5Sun H, Enomoto T, Fujita M, et al. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia. Am J Clin Pathol, 2001,115:32~8.
  • 6高谨,彭芝兰,王和,曹泽毅.子宫内膜癌组织中抑癌基因PTEN突变分析[J].实用癌症杂志,2001,16(6):587-590. 被引量:6
  • 7Ito K, Sasano H, Yabuki N, et al. Immunohistochemical study of Ki-67 and DNA topoisomerase Ⅱ in human endometrium. Mod Pathol, 1997,10(4):289~94.

二级参考文献12

  • 1Li J, Yen C,Liaw D,et al. PTEN: a putative protein tyrosine phosphatase gene mutated in human brain, breast,and prostate cancer[J ]. Science, 1997,275(3) :1943.
  • 2Maehama T,Dixion JE. The tumor suppressor,PTEN/MMAC1, dephosphorylates the lipid second messenger,phosphatidylinositol 3, 4, 5-trisphosphate [J ]. J Biol Chem, 1998,273(5): 13375.
  • 3Tamura M,Gu ],Matsumoto K,et al. Inhibition of cell migration,spreading, and focal adhesions by tumor suppressor PTEN[J]. Science, 1998,280(6): 1614.
  • 4Gu J,Tamura M, Yamada KM,et al. Tumor suppressor PTEN inhibits integrin-and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways[J]. J Cell Biol, 1998,143 (5): 1375.
  • 5Kong D, Suruki A, Zou TT, et al. PTEN is frequently mutated in primary endometrial carcinomas [J]. Nat Genet, 1997, 17(2): 143.
  • 6Risinger JI, Hayes K, Maxwell GL,et al. PTEN nutation in endometrial cancers is associated with favorable clinical and pathologic characteristics [J]. Clin Cancer Res, 1998,4 (12): 3005.
  • 7Imamura T, Arima T, Kato T,et al. Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas[J]. Int J Cancer, 1992,51(9)51:47.
  • 8Risinger J, Dent GA, Ignar-towbridge D, et al. p53 gene mutations in human endometrial carcinoma[J]. Mol Carcinog, 1992,5(4) :250.
  • 9Steck PA, Perhouse MA,Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in mutiple advanced cancers[J]. Nat Genet, 1997,15(4): 356.
  • 10Tashiro H,Blazes MS,Wu R,et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies [J ]. Cancer Res,1997,57(9) :3935.

共引文献9

同被引文献161

引证文献19

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部